| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.07 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.088 | 0.08 |